Pharmacokinetics of doripenem during high volume hemodiafiltration in patients with septic shock

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration

(2014) J. A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamic Variability beyond That Explained by MICs

(2013) Rachel L. Soon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

(2013) R. P. Dellinger et al.   INTENSIVE CARE MEDICINE

Severe Sepsis and Septic Shock

(2013) Derek C. Angus et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renal Replacement Therapy in Acute Kidney Injury

(2012) Paul M. Palevsky   ADVANCES IN CHRONIC KIDNEY DISEASE

Pharmacodynamics of the Antibacterial Effect of and Emergence of Resistance to Doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in anIn VitroPharmacokinetic Model

(2012) Karen E. Bowker et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics

(2012) Jason A. Roberts et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem

(2011) Iolanda Cirillo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure

(2011) J. Kron et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effect of Hemopurification Rate on Doripenem Pharmacokinetics in Critically Ill Patients Receiving High-flow Continuous Hemodiafiltration

(2011) Yoshifumi OHCHI et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of Resistance

(2010) A. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Doripenem Pharmacokinetics in Critically Ill Patients Receiving Continuous Hemodiafiltration (CHDF)

(2010) Seigo HIDAKA et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Rapid Determination of Meropenem in Biological Fluids by LC: Comparison of Various Methods for Sample Preparation and Investigation of Meropenem Stability

(2009) Karin Kipper et al.   CHROMATOGRAPHIA

Pharmacokinetic–pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients

(2009) Scott A. Van Wart et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Pharmacokinetics, Safety, and Tolerability of Doripenem After 0.5-, 1-, and 4-Hour Infusions in Healthy Volunteers

(2009) Iolanda Cirillo et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury

(2009) J. Bouchard et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION